Cargando…
Identification of a novel signature with prognostic value in triple-negative breast cancer through clinico-transcriptomic analysis
BACKGROUND: Although perceived as a highly aggressive disease, triple-negative breast cancer (TNBC) constitutes heterogeneous features with various outcomes. In this study, we aimed to establish a prognostic signature for patients with TNBC to improve risk stratification. METHODS: Gene expression da...
Autores principales: | Chen, Chao, Lin, Cai-Jin, Li, Si-Yuan, Hu, Xin, Shao, Zhi-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652523/ https://www.ncbi.nlm.nih.gov/pubmed/36388802 http://dx.doi.org/10.21037/atm-22-1931 |
Ejemplares similares
-
Overview of triple negative breast cancer prognostic signatures in the context of data science-driven clinico-genomics research
por: Capobianco, Enrico
Publicado: (2022) -
Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023) -
Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer
por: Zhou, Yi-Fan, et al.
Publicado: (2021) -
The Prognostic Value of Nodal Staging in Triple-Negative Breast Cancer — A Cohort from China
por: Yin, Liu, et al.
Publicado: (2018) -
The 3′UTR signature defines a highly metastatic subgroup of triple-negative breast cancer
por: Wang, Lei, et al.
Publicado: (2016)